Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT03543020
Eligibility Criteria:
Inclusion Criteria:
1. All patients with Central Nervous System tumors (primary/metastatic) undergoing radiation to whole brain/ partial brain.
2. All techniques of radiotherapy used for treatment delivery including VMAT and IMRT.
3. Fractionation regimes- conventional and hypofractionation.
4. Patients with KPS\> 70, Patients able to communicate regarding the treatment side-effects.
5. Eligible patients willing to be a part of the trial.
6. Patients undergoing radiotherapy with or without concurrent Temozolomide
Exclusion Criteria:
1. Patients who have received prior radiotherapy to scalp.
2. Patients that need to be treated for scalp lesion such as squamous cell carcinomas of scalp.
3. Poor neurological status performance patients who are unable to communicate.
4. Prior co-morbidities/ dermatological conditions predisposing to pre-existent excessive hair fall (including Systemic Lupus Erythematosus, Hypothyroidism, Polycystic Ovarian Disease and similar conditions)
5. Patients unwilling to come for follow-up.
6. Patients who are completely bald.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03543020
Study Brief:
Protocol Section:
NCT03543020